hBD-1 vs Endomorphin-1
Head-to-head comparison of hBD-1 (Human beta-defensin 1) and Endomorphin-1 (Tyr-Pro-Trp-Phe-NH2) — benefits, dosing, side effects, research data, and where to buy.
Research Score
| Property | hBD-1 | Endomorphin-1 |
|---|---|---|
| Category | Dental & Oral | Pain Management |
| Full Name | Human beta-defensin 1 | Tyr-Pro-Trp-Phe-NH2 |
| Molecular Weight | 4490 Da | 610.71 Da |
| Half-Life | minutes to hours | Minutes in plasma |
| Amino Acids | 36 | 4 |
| Typical Dose | 1-10 µg/mL in experimental studies | 0.1-10 ug per animal |
| Route | Topical/Intraoral | Intrathecal / subcutaneous |
| Purity | ≥98% | ≥98% |
| Studies Count | 85 | 600 |
| Research Status | Pre-clinical | Pre-clinical |
hBD-1 Benefits
- ✓oral innate immunity
- ✓broad antimicrobial activity
- ✓biofilm suppression
- ✓periodontal support
Endomorphin-1 Benefits
- ✓mu-opioid selectivity
- ✓potent antinociception
- ✓endogenous peptide scaffold
- ✓useful for receptor-discovery studies
hBD-1 Dosing
topical peptide exposure|cell-culture or mucosal models|repeat low-dose application in research
Endomorphin-1 Dosing
Intrathecal 0.1-10 ug per animal|Subcutaneous 0.1-5 ug per animal|In vitro 0.1-100 nM
hBD-1 Side Effects
- ⚠protease degradation
- ⚠local irritation at high dose
- ⚠limited stability in saliva
Endomorphin-1 Side Effects
- ⚠respiratory depression at high exposure
- ⚠sedation
- ⚠tolerance and dependence potential
Research Overview
hBD-1
hBD-1 has been studied as part of the oral mucosal defense system and is linked to host resistance against dental pathogens. Research spans periodontitis, candidiasis, and epithelial barrier biology.
Endomorphin-1
Endomorphin-1 is a key research peptide in studies of endogenous mu-opioid signaling and spinal analgesia. Like other peptide analgesics, its main translational hurdles are enzymatic instability, limited oral bioavailability, and delivery across barriers.
Ready to buy?
Find both peptides from our verified, lab-tested vendors with purity certificates and third-party testing.